HSBC Holdings’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,177
| Closed | -$383K | – | 2700 |
|
|
2025
Q1 | $383K | Sell |
13,177
-4,342
| -25% | -$126K | ﹤0.01% | 1791 |
|
|
2024
Q4 | $507K | Buy |
17,519
+9,230
| +111% | +$267K | ﹤0.01% | 1775 |
|
|
2024
Q3 | $368K | Sell |
8,289
-5,436
| -40% | -$241K | ﹤0.01% | 1842 |
|
|
2024
Q2 | $561K | Sell |
13,725
-1,380
| -9% | -$56.4K | ﹤0.01% | 1588 |
|
|
2024
Q1 | $385K | Sell |
15,105
-3,520
| -19% | -$89.8K | ﹤0.01% | 1861 |
|
|
2023
Q4 | $169K | Buy |
18,625
+5,767
| +45% | +$52.4K | ﹤0.01% | 2046 |
|
|
2023
Q3 | $80.7K | Buy |
+12,858
| New | +$80.7K | ﹤0.01% | 2075 |
|